ArticleJournal of neurosurgery. Case lessons2025
Reclassification of pineal tumor as high-grade astrocytoma with piloid features through methylation profiling: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort.Neuro-oncology · 2026Article
- High-grade astrocytoma with piloid features: a case report of comprehensive management.Frontiers in oncology · 2026Article
- High-grade astrocytoma with piloid features resected with an exoscopic supracerebellar infratentorial approach: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe recent WHO 2021 CNS classification system defines new tumor types and subtypes based on molecular features. Among them, high-grade astrocytoma with piloid features (HGAP) is a glioma subtype whose classification depends on its DNA methylation profiling signature. These tumors can have a varied histological appearance and are often misclassified. OBSERVATIONS: A 41-year-old male presented with right-sided weakness and headache. MRI detected a heterogeneously enhancing mass in the pineal region. The patient underwent an endoscopic third ventriculostomy, and a biopsy sample was obtained. The pathology was initially consistent with a high-grade neuroepithelial tumor. Repeat imaging 3 weeks postoperatively demonstrated an interval increase in tumor size. He underwent a suboccipital craniectomy for gross-total resection. DNA methylation profiling was performed and was consistent with the diagnosis of HGAP. The patient was given chemoradiotherapy due to the high-grade pathology. LESSONS: Integration of molecular pathology has led to crucial and clinically relevant changes in CNS tumor classification. Utilizing these advanced diagnostic techniques to classify tumors could lead to changes in management, targeted therapeutics, and enrollment in clinical trials. https://thejns.org/doi/10.3171/CASE24778.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.